| A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation E Grassilli, F Pisano, A Cialdella, S Bonomo, C Missaglia, MG Cerrito, ... Oncogene 35 (33), 4368-4378, 2016 | 67 | 2016 |
| Macrophage-derived nanovesicles exert intrinsic anti-inflammatory properties and prolong survival in sepsis through a direct interaction with macrophages R Molinaro, A Pastò, C Corbo, F Taraballi, F Giordano, JO Martinez, ... Nanoscale 11 (28), 13576-13586, 2019 | 58 | 2019 |
| Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategy A Pasto, F Giordano, M Evangelopoulos, A Amadori, E Tasciotti Clinical and translational medicine 8, 1-9, 2019 | 43 | 2019 |
| Biomimetic nanoparticles potentiate the anti-inflammatory properties of dexamethasone and reduce the cytokine storm syndrome: an additional weapon against COVID-19? R Molinaro, A Pasto, F Taraballi, F Giordano, JA Azzi, E Tasciotti, C Corbo Nanomaterials 10 (11), 2301, 2020 | 36 | 2020 |
| p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma F Giordano, V Vaira, D Cortinovis, S Bonomo, J Goedmakers, F Brena, ... Journal of Experimental & Clinical Cancer Research 38, 1-16, 2019 | 31 | 2019 |
| Reproducible and characterized method for ponatinib encapsulation into biomimetic lipid nanoparticles as a platform for multi-tyrosine kinase-targeted therapy A Zinger, G Baudo, T Naoi, F Giordano, S Lenna, M Massaro, A Ewing, ... ACS Applied Bio Materials 3 (10), 6737-6745, 2020 | 25 | 2020 |
| Biomimetic cellular vectors for enhancing drug delivery to the lungs M Evangelopoulos, IK Yazdi, S Acciardo, R Palomba, F Giordano, A Pasto, ... Scientific Reports 10 (1), 172, 2020 | 18 | 2020 |
| Optimization of biomimetic, leukocyte-mimicking nanovesicles for drug delivery against colorectal cancer using a design of experiment approach R Rampado, A Biccari, E D’Angelo, F Collino, G Cricrì, P Caliceti, ... Frontiers in Bioengineering and Biotechnology 10, 883034, 2022 | 6 | 2022 |
| LDL-based lipid nanoparticle derived for blood plasma accumulates preferentially in atherosclerotic plaque CA Boada, A Zinger, S Rohen, JO Martinez, M Evangelopoulos, ... Frontiers in Bioengineering and Biotechnology 9, 794676, 2021 | 5 | 2021 |
| Optimization of a detergent-based protocol for membrane proteins purification from mammalian cells R Rampado, F Giordano, L Moracci, S Crotti, P Caliceti, M Agostini, ... Journal of Pharmaceutical and Biomedical Analysis 219, 114926, 2022 | 3 | 2022 |
| Nanodelivery systems face challenges and limitations in bone diseases management F Giordano, S Lenna, R Rampado, A Brozovich, T Hirase, MG Tognon, ... Advanced Therapeutics 4 (12), 2100152, 2021 | 3 | 2021 |
| Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma F Giordano, S Lenna, G Baudo, R Rampado, M Massaro, E De Rosa, ... Cancer Nanotechnology 13 (1), 40, 2022 | 2 | 2022 |
| Nanodelivery Systems Face Challenges and Limitations in Bone Diseases Management (Adv. Therap. 12/2021) F Giordano, S Lenna, R Rampado, A Brozovich, T Hirase, MG Tognon, ... Advanced Therapeutics 4 (12), 2170036, 2021 | 1 | 2021 |
| Ponatinib loaded leukocyte-based nanoparticles for osteosarcoma treatment in sarcosphere tumor model F Giordano, S Lenna, R Rampado, A Ewing, G Baudo, M Massaro, ... Cancer Research 81 (13_Supplement), 311-311, 2021 | 1 | 2021 |
| Macrophage-derived nanovesicles exert intrinsic anti-inflammatory properties through a direct interaction with macrophages and prolong survival in sepsis R Molinaro, A Pasto, C Corbo, F Taraballi, F Giordano, JO Martinez, ... Nanoscale, 2019 | 1 | 2019 |
| p65BTK is a novel therapeutic target in solid tumors D Conconi, F Giordano, V Vaira, S Bonomo, MG Cerrito, L Ianzano, ... EUROPEAN JOURNAL OF CANCER 103, E10-E10, 2018 | 1 | 2018 |
| Correction: A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation E Grassilli, F Pisano, A Cialdella, S Bonomo, C Missaglia, MG Cerrito, ... Oncogene, 2024 | | 2024 |
| Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease C Mancino, J Pollet, A Zinger, KM Jones, MJ Villar, AC Leao, R Adhikari, ... ACS Applied Materials & Interfaces, 2024 | | 2024 |
| Leukosome-based siRNA strategy for targeting ribosomal protein L39 (RPL39) in metaplastic breast cancer MF Chervo, C Mancino, F Giordano, TP Reddy, W Qian, J Zhou, ... Cancer Research 83 (7_Supplement), 2709-2709, 2023 | | 2023 |
| Ponatinib loaded leukocyte-based nanoparticles: A new platform for treating osteosarcoma F Giordano, S Lenna, R Rampado, G Baudo, M Massaro, A Rivera, ... Cancer Research 82 (12_Supplement), 307-307, 2022 | | 2022 |
